Prize4Life Inc

“The organization's representative reviews the irs form 990 with the accountant and makes a recommendation to the board to approve. Prior to the submission all board members receive a pdf copy of the return.”

“The policy states: "in connection with any actual or possible conflict of interest, an interested person must disclose the existence of the financial interest and be given the opportunity to disclosure all material facts to the directors and members of committees with governing board delegated powers considering the proposed transaction or arrangement.”

“The board reviews compensation as part of the annual budget approval process.”

“The board reviews compensation as part of the annual budget approval process.”

“Governing documents are made available upon request or via the state of massachusetts secretary of state website.”

“Members of the scientific community provide their service to review "prize" entries to make recommnedations to enhance protocols to further research.”

“Global als collaboration: als observes no geographic boundaries and neither does prize4life. Prize4life values the sharing of ideas, information, and knowledge among a wide variety of research sectors around the globe as well as within the organization itself. Prize4life is committed to facilitating collaboration as an effective means to the fulfillment of its mission. Efficiency/leverage: als patients deserve a cure today and we hope to find it for them, working quickly and without waste of time or resources. We identify and partner to develop the necessary missing tools, resources, and projects that will transform the als drug development landscape. We proactively seek to learn where other als-related organizations are focusing their efforts in order to avoid creating redundancies. The prizes in november 2006, prize4life launched its first prize challenge, a 1 million award to be given for the discovery of a clinically relevant biomarker for als that could easily and effectively track disease progression. In may 2007, with a 75,000 donation from the kraft family, prize4life awarded five thought prizes of 15,000 each to teams who proposed the best theoretical solutions for discovering a biomarker for als. We continued to work towards awarding the 1 m biomarker prize and set a submission deadline of november 6, 2008. Prize4life received 12 submissions from 7 different countries. In 2009, prize4life awarded two submissions prizes of 50,000 each to recognize the progress and potential of their work. The 1 million prize was re-opened with a rolling deadline ending may 2011, and was ultimately awarded to dr. Seward rutkove in february of 2011 for the development of a biomarker that utilized electrical impedance myography. In october 2008, prize4life launched its second major prize: a 1 million award for a therapy that reliably and effectively extends the life of als mice by 25%. Named after prize4life's founder and ceo at the request of an anonymous donor, the 1 m avi kremer als treatment prize had a rolling deadline, which was closed to submissions on october 15, 2010. Prize4life received 13 submissions from 4 countries. In 2012 prize4life re-iaunched the 1m avi kremer als treatment prize4life, and by 2014 there were 14 industry and 20 academic teams participating in the prize competition. In addition, in 2012 prize4life launched the als prediction prize for an algorithm capable of improving clinician's ability to predict a given patient's disease progression. Over 1000 teams competed for this prize and 3 teams were awarded 50k in prizes in october 2012. The results of the prize were published in nature biotechnology in 2014, and one of the winning teams has launched a startup company to further develop their award-winning approach for als and other diseases. Other programs: while prizes are the visible core of our results-oriented model, we are also conscious of the need to create a vibrant and supportive arena in which our participating teams can effectively compete. Prize4life offers various tools to help support competing teams and the als research community as a whole: the prlze4life-jackson laboratory mouse colony after the launch of the 1m avi kremer treatment prize4life (als treatment prize) and to facilitate a diverse pool of teams and assist solvers competing for the als treatment prize, prize4life partnered with the jackson laboratory, a leading provider of mouse models for research, to build a mouse colony to provide quality controlled mice to competing labs free of charge. Since the mouse colony re-launch in sept 2011, this resource has enabled researchers from academia and industry to test more than 25 new candidate als therapies in the sod1-g93a als mouse model. The mouse manual to ensure that the outcomes from studies using free mouse models are useful. Prize4life worked with the jackson laboratory to write "working with als mice: guidelines for preclinical testing & colony management," a document intended to shar”

“Subcontracted services 226,791 0 0 consultant 0 21,359 0”